{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:49:01Z","timestamp":1791550141893,"version":"4.3.4"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sexual Medicine Reviews"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.sxmr.2021.03.006","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T04:44:57Z","timestamp":1625287497000},"page":"42-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Topical Corticosteroids in the Treatment of Vulvar Lichen Sclerosus: A Review of Pharmacokinetics and Recommended Dosing Frequencies"],"prefix":"10.1093","volume":"10","author":[{"given":"Theodora T.","family":"Mautz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill M.","family":"Krapf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1016\/j.sxmr.2021.03.006_bib0001","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/bjd.16241","article-title":"British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018","volume":"178","author":"Lewis","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0002","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/jdv.13136","article-title":"Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus","volume":"29","author":"Kirtschig","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0003","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1479-828X.2010.01142.x","article-title":"Long-term management of vulval lichen sclerosus in adult women","volume":"50","author":"Bradford","year":"2010","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0004","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jamadermatol.2015.0643","article-title":"Long-term management of adult vulvar lichen sclerosus: a prospective ohort study of 507 women","volume":"151","author":"Lee","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0005","series-title":"Temovate (R) (clobetasol propionate cream and ointment) Product Information","year":"2000"},{"issue":"Suppl 5","key":"10.1016\/j.sxmr.2021.03.006_bib0006","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2165\/00003495-198800365-00011","article-title":"Clinical pharmacology and pharmacokinetic properties of topically applied corticosteroids. A review","volume":"36","author":"Goa","year":"1988","journal-title":"Drugs"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0007","first-page":"7","article-title":"Topical corticosteroids: Mechanisms of action","volume":"151","author":"Kragballe","year":"1989","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0008","series-title":"StatPearls","article-title":"Topical Corticosteroids [Internet]","author":"Gabros","year":"2020"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0009","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ejpb.2007.08.007","article-title":"Bioavailability and bioequivalence of topical glucocorticoids","volume":"68","author":"Wiedersberg","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0010","series-title":"Analogue-based Drug Discovery","author":"Fischer","year":"2006"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0011","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0168-3659(98)00060-1","article-title":"Methods for quantitative determination of drug localized in the skin","volume":"56","author":"Touitou","year":"1998","journal-title":"J Control Release"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0012","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/dta.2412","article-title":"In vitro penetration through the skin layers of topically applied glucocorticoids","volume":"10","author":"Carrer","year":"2018","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0013","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1046\/j.1365-2133.1998.02498.x","article-title":"Frequency of application of topical corticosteroids: An overview","volume":"139","author":"Lagos","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0014","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1007\/s11095-016-1960-y","article-title":"Kinetics of clobetasol-17-propionate in psoriatic lesional and non-lesional skin assessed by dermal open flow microperfusion with time and space resolution","volume":"33","author":"Bodenlenz","year":"2016","journal-title":"Pharm Res"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0015","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4103\/0378-6323.159933","article-title":"The reservoir effect of topical steroids in vitiliginous skin: A cross-sectional study","volume":"81","author":"Singh","year":"2015","journal-title":"Indian J Dermatol Venereol Leprology"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0016","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2133.1976.tb04369.x","article-title":"A new model for human bioassay of topical corticosteroids","volume":"94","author":"Reddy","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0017","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/DAD.0000000000000171","article-title":"Changes of epidermal thickness in vitiligo","volume":"37","author":"Jung","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0018","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1365-2559.1998.00397.x","article-title":"Ki67 expression in lichen sclerosus of vulva in patients with and without associated squamous cell carcinoma","volume":"32","author":"Scurry","year":"1998","journal-title":"Histopathology"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0019","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1590\/S0100-879X2004000100015","article-title":"Measurement of epidermal thickness in a patient with psoriasis by computer-supported image analysis","volume":"37","author":"Alper","year":"2004","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/cyto.b.20575","article-title":"Cellular features of psoriatic skin: Imaging and quantification using in vivo reflectance confocal microscopy","volume":"80B","author":"Wolberink","year":"2011","journal-title":"Cytometry Part B: Clinical Cytometry"},{"issue":"suppl 12","key":"10.1016\/j.sxmr.2021.03.006_bib0021","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2133.1976.tb02279.x","article-title":"Steroid-induced atrophy in an animal and human model","volume":"94","author":"Kirby","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0022","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/014107688708000709","article-title":"Adrenal suppression following low-dose topical clobetasol propionate","volume":"80","author":"Ohman","year":"1987","journal-title":"J R Soc Med"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0023","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4103\/0378-6323.178903","article-title":"Topical corticosteroids in dermatology","volume":"82","author":"Mehta","year":"2016","journal-title":"Indian J Dermatol Venereol Leprology"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0024","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00407888","article-title":"Effects of glucocorticosteroids on cultured human skin fibroblasts. III. Transient inhibition of cell proliferation in the early growth stages and reduced susceptibility in later growth stages","volume":"265","author":"Ponec","year":"1979","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000422366","article-title":"Topical tretinoin prevents corticosteroid-induced atrophy without lessening the anti-inflammatory effect","volume":"21","author":"Kligman","year":"1993","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.01.010","article-title":"Adverse effects of topical glucocorticosteroids","volume":"54","author":"Hengge","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0027","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4103\/2229-5178.142483","article-title":"Side-effects of topical steroids: A long overdue revisit","volume":"5","author":"Coondoo","year":"2014","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0028","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1523-1747.2003.12053.x","article-title":"Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: Inhibition of epidermal lipid synthesis accounts for functional abnormalities","volume":"120","author":"Kao","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0029","first-page":"51","article-title":"Skin atrophy induced by initial continuous topical application of clobetasol followed by intermittent application","volume":"190","author":"Lubach","year":"1995","journal-title":"DRM"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0030","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1365-2133.1997.tb03929.x","article-title":"Depletion of stratum corneum intercellular lipid lamellae and barrier function abnormalities after long-term topical corticosteroids","volume":"136","author":"Sheu","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0031","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1185\/030079908X280419","article-title":"Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas","volume":"24","author":"Draelos","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.17077\/2154-4751.1255","article-title":"Vulvar contact dermatitis","volume":"4","author":"Connor","year":"2014","journal-title":"Proc Obstet Gynecol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0033","series-title":"A treatise on topical corticosteroids in dermatology: use, misuse and abuse","first-page":"159","article-title":"Use and misuse of topical corticosteroid in genital dermatosis","author":"Marfatia","year":"2018"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0034","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1542-2011.2012.00189.x","article-title":"Vulvar skin atrophy induced by topical glucocorticoids","volume":"57","author":"Johnson","year":"2012","journal-title":"J Midwifery Womens Health"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0035","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archderm.140.6.709","article-title":"Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease","volume":"140","author":"Renaud-Vilmer","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0036","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2133.1991.tb00626.x","article-title":"The treatment of vulval lichen sclerosus with a very potent topical steroid (clobetasol propionate 0.05%) cream","volume":"124","author":"Dalziel","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0037","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/LGT.0000000000000162","article-title":"Normal vulvar histology: variation by site","volume":"20","author":"Day","year":"2016","journal-title":"J Lower Genital Tract Dis"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0038","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1046\/j.1365-2133.2000.03833.x","article-title":"Efficacy and safety of wet-wrap dressings in children with severe atopic dermatitis: influence of corticosteroid dilution","volume":"143","author":"Wolkerstorfer","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0039","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1056\/NEJM196510142731601","article-title":"Percutaneous absorption of corticosteroids","volume":"273","author":"Scoggins","year":"1965","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0040","doi-asserted-by":"crossref","first-page":"460","DOI":"10.4103\/0019-5154.139874","article-title":"Systemic side-effects of topical corticosteroids","volume":"59","author":"Dhar","year":"2014","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0041","series-title":"Fitzpatrick\u2019s dermatology in general medicine","article-title":"Chapter 214. principles of topical therapy [Internet]","author":"Souza","year":"2012"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0042","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2230.1983.tb01758.x","article-title":"Investigation of the pharmacokinetics of clobetasol propionate and clobetasone butyrate after a single application of ointment","volume":"8","author":"Hehir","year":"1983","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0043","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF00403852","article-title":"Human percutaneous penetration of hydrocortisone: the vulva","volume":"267","author":"Britz","year":"1980","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0044","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2133.1996.tb07606.x","article-title":"Percutaneous absorption of hydrocortisone and testosterone on the vulva and forearm: effect of the menopause and site","volume":"134","author":"Oriba","year":"1996","journal-title":"British Journal of Dermatology"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0045","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.jaad.2010.06.011","article-title":"A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus","volume":"64","author":"Goldstein","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0046","series-title":"Fitzpatrick\u2019s Dermatology in General Medicine","article-title":"Chapter 216. topical corticosteroids [Internet]","author":"Valencia","year":"2012"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0047","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40272-013-0013-9","article-title":"Topical calcineurin inhibitors for atopic dermatitis: Review and treatment recommendations","volume":"15","author":"Carr","year":"2013","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0048","doi-asserted-by":"crossref","first-page":"18954","DOI":"10.5070\/D3197018954","article-title":"Tachyphylaxis to topical glucocorticoids; What is the evidence?","volume":"19","author":"Taheri","year":"2013","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0049","first-page":"546","article-title":"Failure to demonstrate therapeutic tachyphylaxis to topically applied steroids in patients with psoriasis","volume":"41","author":"Miller","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0050","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.jaad.2014.05.040","article-title":"An investigator-initiated, double-blind, vehicle-controlled pilot study: assessment for tachyphylaxis to topically occluded halobetasol 0.05% ointment in the treatment of psoriasis","volume":"71","author":"Czarnowicki","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0051","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.clindermatol.2005.09.003","article-title":"Tachyphylaxis to topical corticosteroids: the more you use them, the less they work?","volume":"24","author":"Feldman","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0052","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/bjd.12910","article-title":"First randomized trial on clobetasol propionate and mometasone furoate in the treatment of vulvar lichen sclerosus: results of efficacy and tolerability","volume":"171","author":"Virgili","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0053","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/13697137.2017.1343295","article-title":"Lichen sclerosus in women: a review","volume":"20","author":"P\u00e9rez-L\u00f3pez","year":"2017","journal-title":"Climacteric"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0054","doi-asserted-by":"crossref","DOI":"10.2174\/1389201021666200516154310","article-title":"Novel therapeutic approaches and targets for treatment of vulvar lichen sclerosus","author":"Borghi","year":"2020","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0055","article-title":"Vulvar skin disorders throughout lifetime: About some representative dermatoses","volume":"2014","author":"Doyen","year":"2014","journal-title":"Bio Med Res Int"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0056","series-title":"A treatise on topical corticosteroids in dermatology: Use, misuse and abuse","first-page":"159","article-title":"Use and misuse of topical corticosteroid in genital dermatosis","author":"Marfatia","year":"2018"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0057","article-title":"Sensitive skin in the genital area","volume":"6","author":"Farage","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0058","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1396-0296.2004.04005.x","article-title":"Diagnosis and therapy of anogenital lichen planus","volume":"17","author":"Moyal-Barracco","year":"2004","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0059","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2004.11.034","article-title":"The vagina as a route for systemic drug delivery","volume":"103","author":"Hussain","year":"2005","journal-title":"J Control Release"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0060","series-title":"The vulva: Physiology and clinical management","author":"Farage","year":"2017"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0061","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1529-8019.2010.01355.x","article-title":"Vulval lichen sclerosus and lichen planus","volume":"23","author":"McPherson","year":"2010","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0062","first-page":"25","article-title":"Long-term control of vulval lichen sclerosus after treatment with a potent topical steroid cream","volume":"38","author":"Dalziel","year":"1993","journal-title":"J Reprod Med"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0063","first-page":"519","article-title":"Vulvar lichen sclerosus in postmenopausal women: a comparative study for treating advanced disease with clobetasol propionate 0.05%","volume":"23","author":"Diakomanolis","year":"2002","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0064","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0923-1811(91)90027-U","article-title":"Cutaneous responses to topical methyl nicotinate in human forearm and vulvar skin","volume":"2","author":"Elsner","year":"1991","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0065","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1525-1470.1997.tb00247.x","article-title":"Treatment of childhood vulvar lichen sclerosus with potent topical corticosteroid","volume":"14","author":"Fischer","year":"1997","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0066","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/archderm.135.5.525","article-title":"Ultrapotent topical corticosteroid treatment of childhood genital lichen sclerosus","volume":"135","author":"Garzon","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sxmr.2021.03.006_bib0067","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/bjd.12273","article-title":"Proactive maintenance therapy with a topical corticosteroid for vulvar lichen sclerosus: Preliminary results of a randomized study","volume":"168","author":"Virgili","year":"2013","journal-title":"Br J Dermatol"}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052121000330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052121000330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T19:38:11Z","timestamp":1672774691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2050052121000330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2050052121000330"],"URL":"https:\/\/doi.org\/10.1016\/j.sxmr.2021.03.006","relation":{},"ISSN":["2050-0521"],"issn-type":[{"value":"2050-0521","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical Corticosteroids in the Treatment of Vulvar Lichen Sclerosus: A Review of Pharmacokinetics and Recommended Dosing Frequencies","name":"articletitle","label":"Article Title"},{"value":"Sexual Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sxmr.2021.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021, International Society of Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}